Unravelling Plasmodium vivax transmission to Anopheles mosquitoes: Role of naturally acquired transmission blocking immunity and efficacy of novel vaccine and drug candidates

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1141441

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project is aimed at better understanding transmission of P. vivax, the world’s most widely spread malaria parasite. Using a newly established experimental platform that enables us to feed P. vivax infected blood to Anopheles farauti mosquitoes, we can start researching factors in human blood that determine P. vivax infection success, test new vaccine and drug candidates for their ability to block transmission and thus significantly advance science surrounding this neglected parasite.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Career Development Fellowships

Funding Amount: $431,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Parasitology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Papua New Guinea | malaria transmission | malaria vaccine | plasmodium | vector-borne disease

Related Links